171 related articles for article (PubMed ID: 35618952)
1. Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Infect Dis Ther; 2022 Aug; 11(4):1541-1557. PubMed ID: 35618952
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
3. Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome.
Villoslada-Blanco P; Pérez-Matute P; Recio-Fernández E; Íñiguez M; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Sci Rep; 2023 Aug; 13(1):14327. PubMed ID: 37653055
[TBL] [Abstract][Full Text] [Related]
4. Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Jansen D; De Coninck L; Close L; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; Matthijnssens J; Oteo JA
Sci Rep; 2022 Dec; 12(1):21658. PubMed ID: 36522388
[TBL] [Abstract][Full Text] [Related]
5. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
[TBL] [Abstract][Full Text] [Related]
6. Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens.
Baltazar-Díaz TA; Amador-Lara F; Andrade-Villanueva JF; González-Hernández LA; Cabrera-Silva RI; Sánchez-Reyes K; Álvarez-Zavala M; Valenzuela-Ramírez A; Del Toro-Arreola S; Bueno-Topete MR
Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110374
[TBL] [Abstract][Full Text] [Related]
7. The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients.
Quiros-Roldan E; Castelli F; Bonito A; Vezzoli M; Calza S; Biasiotto G; Zanella I;
Cytokine; 2020 Feb; 126():154884. PubMed ID: 31670006
[TBL] [Abstract][Full Text] [Related]
8. Characterization of gut microbiota composition in HIV-infected patients with metabolic syndrome.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Physiol Biochem; 2019 Aug; 75(3):299-309. PubMed ID: 30924020
[TBL] [Abstract][Full Text] [Related]
9. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
10. Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy.
Gagliardini R; Gianotti N; Maggiolo F; Cozzi-Lepri A; Antinori A; Nozza S; Lapadula G; De Luca A; Mussini C; Gori A; Saracino A; Andreoni M; Monforte AD;
Int J Antimicrob Agents; 2021 Oct; 58(4):106406. PubMed ID: 34293454
[TBL] [Abstract][Full Text] [Related]
11. Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
Acharya A; Tagny CT; Mbanya D; Fonsah JY; Nchindap E; Kenmogne L; Jihyun M; Njamnshi AK; Kanmogne GD
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106437
[No Abstract] [Full Text] [Related]
12. Gut microbiota diversity predicts immune status in HIV-1 infection.
Nowak P; Troseid M; Avershina E; Barqasho B; Neogi U; Holm K; Hov JR; Noyan K; Vesterbacka J; Svärd J; Rudi K; Sönnerborg A
AIDS; 2015 Nov; 29(18):2409-18. PubMed ID: 26355675
[TBL] [Abstract][Full Text] [Related]
13. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection.
Park TE; Mohamed A; Kalabalik J; Sharma R
Expert Rev Anti Infect Ther; 2015; 13(10):1195-212. PubMed ID: 26293294
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Contemporary Antiretroviral Drugs on Atherosclerosis and Its Complications in People Living With HIV: A Systematic Review.
Vemulapalli AC; Elias AA; Yerramsetti MD; Olanisa OO; Jain P; Khan QS; Butt SR
Cureus; 2023 Oct; 15(10):e47730. PubMed ID: 38021858
[TBL] [Abstract][Full Text] [Related]
15. Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
Sessa L; Reddel S; Manno E; Quagliariello A; Cotugno N; Del Chierico F; Amodio D; Capponi C; Leone F; Bernardi S; Rossi P; Putignani L; Palma P
AIDS; 2019 May; 33(6):1001-1011. PubMed ID: 30946154
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
[TBL] [Abstract][Full Text] [Related]
17. The microbial metabolite trimethylamine-N-oxide in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
Missailidis C; Neogi U; Stenvinkel P; Trøseid M; Nowak P; Bergman P
AIDS; 2018 Jul; 32(12):1589-1598. PubMed ID: 29620717
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the gut bacterial microbiota in rhesus macaques with SIV infection and on short- or long-term antiretroviral therapy.
Siddiqui S; Bao D; Doyle-Meyers L; Dufour J; Wu Y; Liu YZ; Ling B
Sci Rep; 2020 Nov; 10(1):19056. PubMed ID: 33149234
[TBL] [Abstract][Full Text] [Related]
19. Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients.
Imahashi M; Ode H; Kobayashi A; Nemoto M; Matsuda M; Hashiba C; Hamano A; Nakata Y; Mori M; Seko K; Nakahata M; Kogure A; Tanaka Y; Sugiura W; Yokomaku Y; Iwatani Y
Sci Rep; 2021 Jan; 11(1):960. PubMed ID: 33441754
[TBL] [Abstract][Full Text] [Related]
20. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.
Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M
Front Immunol; 2021; 12():688886. PubMed ID: 34135912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
